Abstract. Hyaluronan (HA) and one of its cell binding sites, fibroblast hyaluronan binding protein (HABP), is shown to contribute to the regulation of 10T1/2 cell locomotion that contain an EJ-ras-metaUothionein (MT-1) hybrid gene. Promotion of the rashybrid gene with zinc sulfate acutely stimulates, by 6-10-fold, cell locomotion. After 10 h, locomotion drops to two-to threefold above that of uninduced cells. Several observations indicate increased locomotion is partly regulated by HA. These include the ability of a peptide that specifically binds HA (HABR) to reduce locomotion, the ability of HA (0.001-0.1/zg/ml), added at 10-30 h after induction to stimulate locomotion back to the original, acute rate, and the ability of an mAb specific to a 56-kD fibroblast HABP to block locomotion. Further, both HA and HABP products are regulated by induction of the ras gene. The effect of exogenous HA is blocked by HABR, is dose-dependent and specific in that chondroitin sulfate or heparan have no significant effect. Stimulatory activity is retained by purified HA and lost upon digestion with Streptomyces hyaluronidase indicating that the activity of HA resides in its glycosaminoglycan chain. Uninduced cells are not affected by HA, HABR, or mAb and production of HA or HABP is not altered during the-experimental period. These results suggest that ras-transformation activates an HA/HABP locomotory mechanism that forms part of an autocrine motility mechanism. Reliance of induced cells on HA/HABP for locomotion is transient and specific to the induced state.
binding sites, fibroblast hyaluronan binding protein (HABP), is shown to contribute to the regulation of 10T1/2 cell locomotion that contain an EJ-ras-metaUothionein (MT-1) hybrid gene. Promotion of the rashybrid gene with zinc sulfate acutely stimulates, by 6-10-fold, cell locomotion. After 10 h, locomotion drops to two-to threefold above that of uninduced cells. Several observations indicate increased locomotion is partly regulated by HA. These include the ability of a peptide that specifically binds HA (HABR) to reduce locomotion, the ability of HA (0.001-0.1/zg/ml), added at 10-30 h after induction to stimulate locomotion back to the original, acute rate, and the ability of an mAb specific to a 56-kD fibroblast HABP to block locomotion. Further, both HA and HABP products are regulated by induction of the ras gene. The effect of exogenous HA is blocked by HABR, is dose-dependent and specific in that chondroitin sulfate or heparan have no significant effect. Stimulatory activity is retained by purified HA and lost upon digestion with Streptomyces hyaluronidase indicating that the activity of HA resides in its glycosaminoglycan chain. Uninduced cells are not affected by HA, HABR, or mAb and production of HA or HABP is not altered during the-experimental period. These results suggest that ras-transformation activates an HA/HABP locomotory mechanism that forms part of an autocrine motility mechanism. Reliance of induced cells on HA/HABP for locomotion is transient and specific to the induced state.
H
YALURONAN has been implicated in a variety of disease, homeostatic, and developmental processes (1, 14) . Although the manner in which it exerts its effects is not clear, an increasingly common paradigm is a correlation of an increased but transient production of hyaluronan (HA) 1 that coincides with rapid cell migration during processes such as inflammation, wound repair (50, 51) , tumor invasion (15, 30, 35, 38) , and the morphogenesis of a variety of tissues (4, 5, 35, 36) . It has been proposed that HA promotes cell locomotion, in part, by interacting with the cell surface (7, 38) . Hyaluronan binds to the cell surface via several mechanisms: ionically as a coat, by a covalently attached integral protein (12, 14, 35) , and by specific-binding sites that have been proposed to include integral glycoproteins (6, 17, 21-23, 26, 45, 47) . One of these proteins, termed fibroblast hyaluronan binding protein (HABP) (41, 45) has been particularly implicated in the regulation of cell locomotion (40, 41) . This protein is concentrated in the lamellae and protrusions of rapidly locomoting cells but is reduced or absent on slowly moving or stationary cells (42) . Reconstitution of stationary embryonic fibroblast monolayers with HABP renders them responsive to HA as detected by increased random locomotion (42) . This paper demonstrates that HA promotes the locomotion of 10T1/2 fibroblasts that have been stably transfected with a mutant ras-metallothionein hybrid gene (212 cell line; 37) only when the mutant gene is induced with heavy metal. Responsiveness to HA is transitory and mediated by HABP as demonstrated by antibody-blocking experiments. These results provide evidence for the proposal that endogenous HA production forms part of an autocrine mechanism for stimulating tumor cell locomotion and also provides direct evidence implicating HABP as a mediator of HApromoted locomotion. The 212 cell line will be a useful model to study the molecular mechanisms of HA-HABPdriven locomotion and to dissect the role of activated ras in this process. The implications for the role of HA and HABP in disease, homeostatic, and developmental processes that involve cell locomotion are discussed in light of these findings.
Materials and Methods

Cell Culture
The 212 ceil line was a kind gift of Dr. T. Haliotis (Cancer Research Laboratories, Queens University, Kingston, Canada) and is a 10T1/2 cell line that has been transfected with EJ-ras gene linked to a neomycin construct and metallothionein (MT-1) promoter (37) . Ceils were routinely maintained in DMEM plus 10% FCS (complete medium) containing geneticin G-418 (Sigma Chemical Co., St. Louis, MO; 1 mg/ml) for selection of the neomycin construct. For experimental analysis, cell cultures were subcultured at a dilution of 1:10 and cultured for 24-48 h before the addition of zinc sulfate or buffer alone. This allowed for '~50% culture confluence. At this degree of confluence, uninduced cells locomoted slowly. However, for stock cultures, cells were routinely subcultured at a 1:50 dilution as described by Trimble et al. (37) . The promotion of the ras gene after the addition of zinc sulfate was confirmed by immunoprecipitation of p21ras and by Northern blot analysis of ras message (24; and results not shown). Zinc sulfate did not affect the locomotion of either the parent (10T1/2) cell line or a line that had been transfected with the neomycin MT-1 promoter construct alone (data not shown).
Time-Lapse Cinemicrography
Time-lapse cinemicrography was conducted as described previously (10) using nuclear displacement as a measure of random locomotion. Results obtained with this method were confirmed with a program ("Dynacell"; Zeiss, Oberkochen, FRG) that is based upon Fourier analysis of cell motility incorporating such parameters as net translation, undulation, ruffling, cell shape changes, and pseudopodal extension, quantified together as a motility index (29) . For routine displacement assays, cell motility was monitored on a microscope (model IM35; Zeiss) equipped with a 10X objective and a video camera. During the filming period, cells were maintained in either DMEM alone or complete media (DMEM + 10% FCS) that had been depleted of HA by chromatography of media on an HABR-Sepharose affinity column. HA removal was monitored by measuring levels of this polymer with a Pharmacia Kit (Pharmacia Fine Chemicals, Piscataway, NJ; see below). All cultures were maintained at pH 7.2. Locomotion was observed at varying times after the induction of the mutant-hybrid gene with zinc sulfate and filmed for 1-2-h periods. At least 100 cells were observed for each assay and the results were expressed as means (#m/rain) + SEM.
Addition of Glycosaminoglycans
HA was obtained from several biological sources including human umbilical cord (type I; Sigma Chemical Co.), rooster comb (Healon; Pharmacia Fine Chemicals), and bacteria (Diagnostic Products Corp., Los Angeles, CA). The molecular weight for each preparation was disperse but ranged among 40,000 (bacterial), I million (umbilical cord), and 10 million (HeaIon). All HA preparations were tested for the presence of contaminating protein and other glycosaminoglycans. HA from the human umbilical cord preparation contained variable amounts of protein as well as chondroitin sulfate A and C (43) . HA obtained from bacteria was contaminated with variable amounts of protein but contained no other glycosaminoglycans; rooster comb preparations did not contain detectable protein or other glycosaminoglycans. To purify HA preparations free of possible contaminating growth factors and endotoxin that might affect cell locomotion, the following procedures were used. HA (1 mg/rul) was chromatographed on a Sephadex G-200 column (1 cm × 60 cm; flow rate 1 ml/h) in 2.0 M NaCI buffer at pH 3.0 described for removing growth factors from the related glycosaminoglycan, heparin (19) . These conditions will also remove an HA-bound growth factor (16) . HA, eluted in the void volume, was detected by a carbazole reaction (2) then chromatographed on an affinity column (toxigel; Pharmacia Fine Chemicals) to adsorb endotoxin. The purified HA did not contain detectable protein as judged by absorption at 280/260 nor did it affect [3H]thymidine incorporation in a serum-starvation culture assay (9) . An effect would be predicted to occur if HA was complexed with a growth factor that could be slowly released or if, conversely, HA bound to growth factors present in growth media to render them inactive. Heparin (pig mucosal lining) and chrondroitin sulfate (type A and C; shark cartilage) were purchased from Sigma Chemical Co. To digest HA to tetrnsaccharides, Streptomyces hyaluronidase (100 IU/mi; Miles Scientific Die., Naperville, IL) was added to a 100 #g/ml solution of Healon(R) at 37°C for 48 h in a Na2CO3 buffer at pH 5.1 (39) .
Addition of Antibodies and HABR
Monoclonal antibodies were prepared against HABF by injecting mice with 50 #g of HABP, linked to keyhole lymphocyte hvmacyanin, three times over a 4-wk period. 2 wk after the final injection, mice were primed by daily injection of 5 #g of underivatized HABP for 5 d. The spleen was then removed and hybridomas were prepared by fusing spleen cells with NS-I cells using 50% polyethylene glycol. Cells were plated onto peritoneal macrophage feeder layers in HAT medium. Positive colonies were cloned three to four times by limiting dilution and HABP binding was assessed with an ELISA (45) . Clones were injected into mice and nscites obtained were again tested for a positive reaction to HABP with an ELISA. Within several hours of mutant gene induction, cells began to translocate more rapidly reaching a peak of locomotory activity at 4-6 h after gene induction. Thereafter, locomotion dropped to ,,o15 #m/rain, a value that was two-to threefold higher than uninduced cells. This rate was sustained for the remainder of the filming period. (B) HA (.001 #g/ml) had no effect on cell locomotion between 0-10 h or 30-60 h after gene induction (o). However, this glycosaminoglycan promoted locomotion of cells between 10-30 h after mutant gene induction. HA (o) had no effect on locomotion of uninduced cells. Values represent the mean + SEM. n = 100 cells.
All monoclonal antibodies isolated from ascites were IgGl and were purified on both protein-A Sepbarose and HABP-Sepharose affinity colunms (45) . Of the 13 monoclonal antibodies isolated, three were shown to block the locomotion of fibroblasts. One, 3T3-5, was used in this study to probe 212 cell responses to HA. This antibody was added for 1/2 h before the beginning of the 2-h filming period at dilutions of 1:100 (10 #g/nil).
To assess specificity of antibodies, HABP (10-200 #g/nil) was added to , or for 4 h (C), were exposed to either monoclonal antibodies to fibroblast HABP (3T3-5, 3T3-7), other antibodies or to HABR for 1/2 h before filming their locomotory behavior. The effect of these reagents on rate of locomotion in the presence or absence of HA (.001 #g/mD or HABP (20-200 #g/ml) was calculated from cell displacement during a 2-h filming period. Uninduccd cells (A) did not respond to antibodies or to HABR. The locomotion of cells that had been induced for either 24 or 4 h was reduced by both antibodies to HABP and by HABR in the presence or absence of HA. The effect of HABP antibodies was reversed by preincubation of antibody with excess HABP. Antiactin, anti-BSA, and the 3T3-7 monoclonal antibody to HABP bad no effect on HA-promoted cell locomotion. Values represent the mean. n = 100 cells.
neutralize the antibody in sample locomotion assays. HABP added by itself did not, as noted previously (42) have an effect on cell locomotion.
Antibodies to BSA (20 #g/ml; Sigma Chemical Co.) and aetin (20 #g/ml; Sigma Chemical Co.) were used as controls. Nonimmune mouse sera was either purified as described for antibodies to HABP or added as antisera 
Measurement of HA Release
212 cells were subcultured at a 1:10 dilution in 60-mm tissue culture dishes (Nunc, Rosldlde, Denmark) containing HA-depleted growth medium described above. After 24 h, the mutant-hybrid gene was induced, and medium was isolated at 1, 2, 4, 6, 12, 16, 24, 48, 72, and 96 h. Media was also collected at these times in uninduced cultures. The HA present in the media was quantitated using HA Test 50 (Pharmacia Fine Chemicals). All samples were corrected for background using HA-depleted medium: these values were generally below the limits of detection (5 #g/liter). Results were quantified relative to HA standards prepared in this laboratory. Linearity was achieved between 10-100 #g HA/liter. Precision was determined by SEM and judged to be, on average, <10% of the mean.
lmmunofluorescence
Induced and uninduccd 212 cells were grown on glass coverslips, fixed for 10 rain in freshly prepared 3% paraformaldehyde then incubated in 1.0 M glycine to reduce unreactcd aldehyde groups (40) . Cultures were incubated with mAb to HABP (3T3-7; 1 #g/ml in DMEM + 10% calf serum) for 2 h 212 cells were sparsely subcultured and the mutant hybrid gene was induced with zinc sulfate for 24 h. Cells were then exposed to 0.0001-100 #g/ml of glycosaminoglycan. Data presented in this figure included 0.001 #g/ml only, but results were similax to the other concentrations that were examined. The rate of locomotion was calculated from a 2-h filming period. Statistical analysis of data indicated that only HA-stimulated cell locomotion (p < 0.05).
Values represent the mean + SEM. n = 100 cells. Cultures of 212 cells were induced with zinc sulfate for 24 h and then exposed to the above treatments for an additional 2 h for analysis of cell locomotion. Umbilical cord HA was purified by gel filtration in 2 M NaCI at pH 3.0 to remove putative growth factors and chromatographed on a toxigel column to remove possible endotoxin contamination. Values represent means 5: SEM. n = 100 cells.
at room temperature or for 24 h at 4°C. Excess antibody was removed by washing and monolayers were incubated with Fab t RITC-anti-mouse IgG (Sigma Chemical Co., 1:1,000 dilution) for I h at room temperature. Excess antibody was removed by washing and ceils wcrc examined with epifluorescence. 
Immunoprecipitation Assays
After subculture, 212 cells were grown for 24 h in DMEM + 10% FCS and exposed to 30 /~M zinc sulfate or buffer alone together with Trans[35S]methionine/cysteine (100/~Ci/rnl; specific activity is 1,100 Ci/ml; ICN Radiochemicals, Irvine, CA) for an additional 24 h. The cell layer was extracted with lysis buffer (10 mM Na2HPO4, 154 mM NaCI, 1% Triton X-100, 0.5 % sodium deoxycholate, and 0.1% sodium dodecyl sulfate, 1 #M leupeptin (Sigma Chemical Co.); Aprotinin, 1,000 KU/ml, and phenylmethyl sulfonamide, 1 #g/ml (Sigma Chemical Co.) and lysates were spun at 25,000 g (DuPont Co., Sorvall Instruments Div., Newton, CT) for 60 min (24) . To normalize lysates for protein content, a sample was precipitated with 10% TCA and a constant amount of radioactivity was used for immunoprecipitation assays. Samples were incubated with the 3T3-7 rnAb to HABP (0.1 #g/ml) or preimmune sera for 2 h on ice. The antibody was adsorbed for 2 h with anti-mouse IgG-Staphylococcus aureus (10% vol/ vol). Adsorbed antibody was washed in lysis buffer and then electrophoresed on 12.5 % SDS-PAGE. Immunoprecipitated proteins were detected by autoradiography.
Results
Induction of the Mutant Ras-Hybrid Gene-promoted Cell Locomotion
Within 1-2 h after induction of the EJ-ras hybrid gene with zinc sulfate, an acute increase in the random locomotion of 212 cells was observed (Fig. 1 A) . The rate of locomotion peaked between 2-5 h at ,~48/~m/min. By 10 h, this rate had dropped to 15-20/~m/min (Fig. 1 A) . In contrast, the locomotion of uninduced 212 cells was '~5/~m/min, eight-to ninefold less than the maximum rate of induced cells. Locomotion ofuninduced cells gradually decreased to <1/~m/min by 72 h after subculture (Fig. 1 A) . The increase in locomotion resulting from induction of the mutant ras-hybrid gene occurred before promotion of [3H]thymidine incorporation (data not shown). Several observations suggested that the increase in cell locomotion resulting from zinc induction of the mutant hybrid gene was regulated in part, by the glycosaminoglycan, HA, and by fibroblast HABP (Figs. 1 and 2 ).
Exogenous HA-stimulated Locomotion of Induced Cells
The addition of HA to 212 cells 24 h after zinc induction of the mutant hybrid gene-stimulated locomotion approximately threefold (Figs. 1 B, 2, and 3 ). This rate of locomotion approximated the rate observed after initial induction of the mutant gene (Fig. 1, A and B) . Addition of HA before or after this time frame had no effect. Further, HA had no effect on locomotion of uninduced cells (Fig. 1 B) .
A response to HA was concentration dependent with maximal stimulation occurring between 0.001-0.1 #g/ml (Fig. 3) . HA was specific in its ability to promote the locomotion of induced 212 cells in that neither heparin nor chondroitin sulfate were statistically effective (Fig. 4) . Several observations also suggested that the effect of HA on cell locomotion was not because of the presence of contaminating factors possibly associated with HA preparations (Table I) . Complete digestion of HA to tetrasaccharides with Streptomyces hyaluronidase, under conditions that controlled for protease activity, abolished the stimulatory effect of HA on cell locomotion. HA, purified to remove both growth factors and endotoxin, retained its ability to promote locomotion. Consistent with this, HA did not influence pH]thymidine ineor- poration (data not shown). HA isolated from such divergent species as mammals and bacteria also displayed similar stimulatory activities (Table I) .
Fibroblast H A B P Mediated the Effect of HA on Induced Cell Locomotion
HABR, added at levels calculated to bind 10 #g HA, as predicted from an HA test 50 kit (Pharmacia Fine Chemicals) reduced the locomotion of induced 212 cells at 4 h after zinc induction (Fig. 2) . Further, the addition of HABR with exogenous HA negated the stimulatory activity of this glycosaminoglycan (Fig. 2 B) . HABR had no effect on uninduced cells (Fig. 2 A) .
Several observations implicated HABP in the increased locomotion of zinc-induced cells. A neutralizing mAb (3T3-5), specific to a 56-kD HABP (Hardwick, C., H. P. Hohn, M. Hook, E. Taylor, K. Vandeligt, L. Austen, and E. Tudey, manuscript submitted for publication), blocked responsiveness to HA (Fig. 2 B) . The rnAb had no effect on the zincinduced cells activated for longer than 36 h (data not shown) or on the locomotion of uninduced cells (Fig. 2 A) . HABP, added together with mAb (3T3-5), abolished the antibodies' inhibitory activity. Preimmune mouse sera, anti-BSA or anti-actin had no effect on cell locomotion (Fig. 2 B) .
Consistent with an involvement of HABP in responses of HA, expression of this protein was increased between 4-36 h after promotion of the mutant-hybrid gene as indicated by both immunofluorescence (Fig. 5 ) and immunoprecipitation assays (Fig. 6 ) using an mAb (3T3-7, a non-blocking antibody) that is specific to the HABP. As noted previously (49) , HABP occurred within a complex of proteins (HA receptor complex) that electrophoresed at the stackingseparating gel interface. Assays also detected a protein of MWE 48-49 kD that is believed to correspond to the nonglycosylated form of HABP (Hardwick, C., H. P. Hohn, 
Increased Locomotion of Induced Cells Correlated with Increased HA Production
An increase in the production of HA occurred transiently between '~,1-12 h after zinc induction of the mutant hybrid gene, paralleling the transient increase in cell locomotion (compare Figs. 1 and 7) and was similar to the concentration of exogenous HA required to stimulate induced 212 cells (Fig. 3) . Production dropped to undetectable levels (<0.005 #g/ml) by 10 h (Fig. 3 ) but gradually increased to 0.09 #g/ml 24-72 h after zinc induction. The production of HA by uninduced 212 cells was undetectable during the first 18 h but rose gradually to 0.06 #g/ml by 72 h after subculture: HA production was always lower than that of induced cells (Fig. 7) .
Discussion
Expression of a ras oncogene has previously been shown to correlate with increased cell locomotion (28, 48) . We show here that acute induction of this mutant gene activates an autocrine HA-HABP-mediated locomotory mechanism. Data indicate that this mechanism is specific to the induced state, transient, and accounts for ~50% of the observed rasinduced increase in locomotion. With time however, it is disassembled as indicated by a reduction in autocrine production of HA, followed by a loss of responsiveness to both exogenous HA and antibodies to HABP.
Several characteristics of the 212 cell locomotion occurring in response to HA are noteworthy. Firstly, HA-HABP-driven locomotion is associated with the initiation of rapid locomotion. A similar paradigm has been observed in vivo where increased production of HA is associated with the onset of locomotion (15, 35, 38, 50) . Secondly, HA and a functional HABP are transiently produced, as has been ob- In summary, an oncogene-transformed fibroblast model that relies upon HA and HABP for locomotion is described. These results implicate HA and fibroblast HABP as important regulators of cell locomotion during oncogenic transformation and are consistent with a recent report noting that HA is required for tumor cells to respond to a tumor motility factor (52). This model will be useful in dissecting the molecular mechanisms by which HA and one of its cell binding sites, HABP, acts to promote cell locomotion.
